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Abstract 
Objective: To examine the relationship between cardiovascular activity in response to acute 
psychological stress and the antibody response to vaccination.   
Methods: Fifty-seven healthy participants were vaccinated with the trivalent influenza 
vaccine and meningococcal A+C polysaccharides.  Antibody levels were measured at 
baseline and 5-weeks post-vaccination.  Cardiovascular activity was measured at rest, during 
and following a mental arithmetic stress task in 54 participants.   
Results: Participants demonstrating a four-fold increase in antibody titre to the A/Panama 
and B/Shangdong influenza strains and to meningococcal A showed greater blood pressure 
reactions toward the end of the acute stress task.  In addition, there was some evidence of 
delayed diastolic blood pressure recovery in those who were responders to A/Panama and 
B/Shangdong influenza strains.  
Conclusion: The present results suggest that heightened cardiovascular reactivity to stress 
and delayed recovery may not necessarily be detrimental to all aspects of health, and may be 
associated with an enhanced immune response to antigen challenge.  
 
Keywords: acute stress; cardiovascular reactivity; influenza vaccination; meningococcal 
A+C vaccination; 
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Examining the antibody response to medical vaccination is considered a useful model for 
studying the impact of psychological stress on in vivo immune function (1).  The results of 
numerous studies now testify to an association between high levels of psychological stress, 
whether measured as life events exposure or perceived stress, and poorer antibody response 
to a range of vaccinations including hepatitis A (2), hepatitis B, (e.g. (3)); influenza (e.g. 
(4)), rubella (5), and pneumococcus (6).   
The mechanisms by which psychological factors might affect antibody response to 
vaccination remain relatively unclear.  However, functional relationships between the 
neuroendocrine system, including the autonomic nervous system, and the immune system 
have been demonstrated for some time (for a review see (7)).  One method by which 
autonomic nervous system activity can be indirectly assessed is by measuring cardiovascular 
reactivity to acute stress (8).  There is now evidence that the magnitude of cardiovascular 
reactivity is correlated with the extent of stress-elicited variations in both enumerative and 
functional immune measures (see e.g. (9)).  Importantly, the magnitude of the 
immunological changes to acute stress are associated with antibody response to vaccination; 
in vitro, reduced T-cell proliferation to phytohaemaglutinin following an evaluative speech 
task was associated with lower antibody responses to the hepatitis B vaccine (10).     
As far as we are aware, to date only two small studies have investigated the 
association between cardiovascular reactions to acute stress and antibody response to 
vaccination.  In the first, elderly women with lower T-cell responses three months following 
influenza vaccination were reported to exhibit relatively large cardiac reactions to standard 
laboratory stress tasks (11, 12).  In the second, a study of hepatitis B vaccination, 
participants with lower antibody titres following vaccination showed larger cardiac output 
and contractility reactions, but smaller increases in total peripheral resistance to mental 
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arithmetic stress (13). Thus, the evidence linking cardiovascular reactivity to psychological 
stress and vaccination response is, as yet, limited.   
The present study examined the association between cardiovascular reactions to and 
recovery from acute laboratory stress and antibody status following a thymus-dependent 
influenza and a thymus-independent meningococcal A+C vaccination.  The choice of these 
immunologically distinct vaccines allowed comparison of the association between 
cardiovascular reactivity and both thymus-dependent (antibody response involving T- and B-
cells) and thymus-independent (antibody response without T-cell involvement) processes 
within the same population (for a fuller description of these processes, see (4)).  This should 
shed light on the generality of any such association between cardiovascular reactivity and 
vaccination response.  Given preliminary evidence from the two previous vaccination 
studies, it was hypothesised that those showing greater cardiovascular reactions to the acute 
stress task would exhibit a poorer antibody response to vaccination.   
 
Methods 
Participants 
Fifty-seven students (31 males) were recruited from the University of Birmingham.  
None of the participants had ever received influenza, meningococcal A, or A + C vaccines, 
neither had they suffered influenza in the winter prior to participation or meningitis ever.  
They also did not have a current acute infection, chronic medical condition, immune disorder 
(e.g. glandular fever), or any vaccine-related allergies or side-effects.  Pregnant participants 
or those taking prescribed medication (excluding the contraceptive pill) were excluded.  The 
mean age of the participants was 19.8 (SD = 2.3) years and mean body mass index, based on 
reported height and weight, was 23.9 (SD = 3.6).  In terms of ethnicity, 50 described 
themselves as “white”, four as “Asian”, two as “black”, and one as “other”.  Ninety-five 
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percent of the sample reported being non-smokers.  The study was approved by the 
appropriate Research Ethics Committees and all participants provided written informed 
consent. 
 
Study Design 
The study comprised three sessions.  In December / January, participants attended an 
initial session for 45 min, during which time they provided demographic information and 
completed psychosocial questionnaires (data reported elsewhere, see (4)).  They were then 
medically screened for eligibility and vaccinated.  Blood samples were drawn immediately 
prior to vaccination, and five weeks later in order to examine the baseline and peak post-
vaccination antibody levels.  Antibody titres were determined to each of the three influenza 
vaccine components and to meningococcal A and C polysaccharides.  Participants attended 
an individual two-hour laboratory session for acute psychological stress testing 
approximately one month after the five week follow-up (mean =  29 days, SD = 15.4 days).  
 
Blood Samples, Vaccinations and Immunological Assays 
Blood was collected by venepuncture from an antecubital vein in plain tubes (BD 
Vacutainer, Meylan Cedex).  Vaccinations were the Fluarix influenza vaccine (Glaxo 
SmithKline; Batch No: 18705B9) and an AC Vax meningitis A+C vaccination (Glaxo 
SmithKline; Batch No: N357A44D) via intramuscular injections into the upper arms.  The 
Fluarix vaccine contained three viral strains: A/New Caledonia/20/99 (H1N1)-like strain – 
[A/New Caledonia/20/99 (IVR-116)]; A/Moscow/10/99 (H3N2)-like strain 
[A/Panama/2007/99 (RESVIR-17)]; and B/Hong Kong/330/2001-like strain 
[B/Shangdong/7/97].  The clotted blood samples were centrifuged after one hour and serum 
was frozen at −20 °C until assayed.  Anti-influenza antibody titres were measured by the 
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serology laboratory of Glaxo Smith Kline Beecham at Dresden, Germany, using a 
haemagglutination inhibition test as described in the World Health Organisation Manual on 
Animal Influenza Diagnosis and Surveillance (14).  Anti-meningococcal A and anti-
meningococcal C antibodies were assayed at the Public Health Laboratory Service 
Meningococcal Reference Unit, Withington Hospital, Manchester.  Serum Neisseria 
meningitidis serogroup A and C polysaccharide-specific immunoglobulin G levels were 
determined quantitatively, in μg/ml, by a standardised enzyme-linked immunosorbent assay 
(ELISA).  A four-fold increase from pre-vaccination baseline is considered the clinical 
criterion of adequate protection (4, 15-17).  Accordingly, the a priori intention was to 
classify participants as responders and non-responders to each viral strain on the basis of 
whether or not they registered a four-fold or greater increase in antibody titre from baseline 
to follow-up.   
 
Laboratory Stress Task  
The psychological stress task was the paced auditory serial addition test which has 
been observed in numerous studies to reliably perturb cardiovascular function and 
demonstrates high test-retest reliability (18).  Participants were presented with a series of 
single digit numbers by audiotape and required to add a number to the number presented 
next, saying the answer out loud. They also had to retain the last number heard in order to 
add it to the next one.  The 8-minute task consisted of four consecutive two minute periods 
of 50, 65, 75 and 100 digits at presentation rates of 2.4, 2.0, 1.6, and 1.2 seconds 
respectively.  The experimenter sat 1 m distant from and adjacent to the participants and 
scored their answers. The task also involved elements of competition and social evaluation.  
A leader board was displayed prominently and participants informed that they should 
attempt to beat the five scores on the board.  They were awarded 1000 points at the start of 
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the task but lost five points for every addition they failed to compute correctly.  The final 
points total served as the performance score. Participants were videotaped and informed that 
the tapes would be assessed by “independent body language experts”; no such assessment 
was made.  They were also able to see themselves live on a television screen in front of them 
throughout the task and were instructed to watch the television at all times.  Finally, they 
received a brief burst of loud, aversive noise once during the first five of every ten trials, 
coincident with an error where one was made and at the end of the series of five if there were 
no errors. This ensured standardized exposure to these aversive stimuli among participants.  
The mean (SD) performance score, was 252.9 (176.2). 
 
Laboratory Session Procedure 
Participants were instructed not to eat, drink, and smoke for one hour prior to arrival at 
the laboratory.  They were also asked to refrain from drinking caffeine for two hours, and 
from exercise and alcohol for 12 hours before the session.  Systolic and diastolic blood 
pressure and heart rate responses were measured using a semi-automatic oscillometric blood 
pressure monitor (Dinamap 1846, Critikon).  A brachial blood pressure cuff was attached to 
the non-dominant arm and measurements were initiated manually every two minutes.  On 
arrival, participants had the procedure explained, and the blood pressure cuff attached.  They 
were allowed a brief practice at the mental arithmetic task.  Participants were then exposed 
to three consecutive conditions: a 20-minute baseline rest period (rest), an 8-minute mental 
stress task (task), and a 30-minute recovery rest period (recovery).  The last eight minutes of 
baseline were taken as the formal baseline for recording purposes, and a blood pressure 
reading was initiated every two minutes during this period, and every two minutes during the 
task and recovery periods.   Sessions started at either 14:00 or 16:00 p.m. and lasted 
approximately two hours.   
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Data Reduction and Analysis 
As indicated, systolic and diastolic blood pressure and heart rate data were available 
for every second minute of the laboratory session yielding 23 data points for each variable.  
Inspection of the raw data indicated that for heart rate and, to a lesser extent, diastolic blood 
pressure there was an anticipatory effect apparent in the final minute of the baseline period 
(minute 8).  Accordingly, baseline was calculated from the average of minutes 2, 4, and 6, 
and minute 8 was designated as anticipation.  Minutes 26, 36 and 46 were omitted from the 
analyses because of perturbations caused by movement during saliva sampling (data not 
reported here).  From minute 22 onwards (during recovery), participants had returned to 
baseline and blood pressure and heart rate values were subsequently stable over time, i.e. 
there was substantial redundancy of values in the later part of recovery.  Thus, these later 
recovery values were averaged across adjacent pairs of sampling points since fewer data 
points were required to depict the unchanging character of later recovery.  This strategy also 
helped defend against the possibility that such homogeneity of values would mask any 
vaccine response effects during the task and earlier in recovery where temporal change was 
at its greatest.  Cardiovascular change scores were computed by subtracting the average 
baseline from subsequent values, yielding 12 change score values, consisting of anticipation 
(minute 8), task reactivity (minutes 10, 12, 14, 16), and recovery (minutes 18 and 20, and the 
average of minutes 22 and 24, 28 and 30, 32 and 34, 38 and 40, and 42 and 44) for each 
cardiovascular variable.  These change scores were analysed using repeated-measures 
multivariate analysis of variance (MANOVA) to compare the pattern of cardiovascular 
change over the 12 periods between responders and non-responders to each vaccine strain.  
Since attention has recently extended from cardiovascular reactions to acute stress to 
recovery patterns (19), it was deemed appropriate to maximize the number of data points 
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included in the analyses.  Potential confounders (age, sex, body mass index, and task 
performance score) were examined for their effect on cardiovascular activity, again using 
MANOVA.  Where a variable was significantly associated with the pattern of cardiovascular 
change, the original models comparing vaccine responders and non-responders were 
revisited adjusting for this variable, by entering it as a covariate in multivariate analyses of 
covariance (MANCOVA).  Partial eta-squared is reported throughout as the measure of 
effect size.  Fifty-five participants were available at five-week follow-up, and 54 attended for 
stress testing.  Other minor variations in degrees of freedom reflect occasional missing data. 
 
Results 
Antibody Status  
For all strains, participants responded with an initial increase in antibody titre from 
baseline at five weeks.  Antibody titres for each vaccine strain are reported elsewhere (4).  
The number of participants with and without a four-fold increase to each of the viral strains 
at each follow-up is presented in Table 1.  As only one participant was a non-responder to 
A/New Caledonia, analysis of four-fold response was not undertaken for this strain.   
 
[Insert Table 1 about here] 
 
Cardiovascular Activity 
Consistent with previous research, the stress task perturbed cardiovascular activity.  
Substantial main effects of period emerged for systolic blood pressure, F(11,40) = 17.46, p 
<.001, η2p = .828, diastolic blood pressure, F(11,41) = 27.67, p <.001, η2p = .884, and heart 
rate, F(11,40) = 12.24, p < .001, η2p = .771.  Blood pressure rose at task onset and had 
largely recovered and stabilised by minute 23, i.e. after 7 minutes of recovery.  Heart rate 
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increased in anticipation of the task, was further perturbed during it, and returned to baseline 
following its completion.    
 
Antibody Status and Cardiovascular Change 
The pattern of anticipation, reactivity, and recovery changes to the mental stress task 
was compared for responders and non-responders to the A/Panama, B/Shangdong influenza 
vaccination strains and meningococcal polysaccharides A and C.  Group × period 
interactions were analyzed to assess whether cardiovascular change over time (i.e. period) 
was associated with antibody status after immunization (i.e. group).  As revealed by 
significant antibody status group × period interaction effects, participants who responded 
with a four-fold increase to the A/Panama viral strain showed a different pattern of systolic, 
F(11,39) = 2.26, p = .03, η2p = .390, and diastolic, F(11,39) = 2.64, p = .01, η2p = .427,  
change than non-responders.  Inspection of Figure 1 indicates that responders exhibited                  
greater blood pressure increases during the second half of the stress task, i.e. during the final 
four minutes of mental arithmetic.  They also showed greater diastolic blood pressure 
increases during anticipation and early in recovery.  Responders and non-responders to the 
B/Shangdong influenza strain also differed in their diastolic blood pressure profile as 
revealed by a significant group × period interaction effect, F(11,39) = 2.08, p = .05, η2p = 
.370.  Figure 1 indicates that the responders showed greater increases in anticipation, during 
early (first two minutes) and later (final four minutes) parts of the mental arithmetic task, and 
during the early part of recovery from the task.   
 
[Insert Figure 1 about here] 
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For meningococcal A, there was also a group × period interaction effect for diastolic 
blood pressure, F(11,39) = 2.07, p = .05, η2p = .369; responders showed greater increases in 
the last two minutes of the stress task.  For the meningococcal C polysaccharide, there was a 
group × period interaction effect for heart rate, F(11,34) = 2.35, p = .03, η2p = .432; 
responders showed higher heart rate in anticipation of the task.  These effects are displayed 
in Figure 2.  The only significant main effect of antibody response group to emerge was for 
the B/Shangdong influenza strain and DBP activity, F(1,49) = 6.03, p = .02, η2p = .110; 
responders had higher aggregate DBP change. 
 
[Insert Figure 2 about here] 
 
Potential Confounders 
MANOVA indicated that there were no significant associations between the pattern 
of cardiovascular change and age, body mass index, and task performance score, treated as 
continuous variables.  However, as indicated by a significant interaction between sex and 
systolic blood pressure change, men showed more pronounced systolic blood pressure 
reactions than women to the stress task, F(11,39) = 2.31, p = .03, η2p = .394.  Accordingly, 
the significant associations between antibody status and systolic blood pressure change were 
revisited, adjusting for sex in MANCOVA.  The difference in systolic blood pressure change 
profile between responders and non-responders to A/Panama remained significant, F(11,38) 
= 2.14, p = .04, η2p = .383.   
 
Discussion 
The present study examined whether cardiovascular reactivity to acute stress was 
associated with antibody response to influenza and meningococcal A+C vaccinations.  The 
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most consistent result to emerge from these analyses was that participants categorised as 
responders, i.e. those who displayed a four-fold increase in antibody titre after vaccination, 
exhibited significantly greater cardiovascular responses during the second half of the stress 
task (the final four minutes of mental arithmetic) than non-responders.  This was evident for 
three of the four antigen strains tested: A/Panama, B/Shangdong, and meningococcal A.  In 
two instances in each case, there were also group differences in anticipation and recovery; 
again it was vaccine responders who had the higher values.  Thus, the most compelling and 
consistent differences between vaccine responders and non-responders were evident for 
blood pressure reactivity.  It is worth noting, however, that there was some evidence of 
delayed recovery in diastolic blood pressure change for responders to both A/Panama and 
B/Shangdong.  This indicates that in studies of cardiovascular change and immune response 
to challenge, it is important measure both reactivity to and recovery from acute stress, as 
both heightened reactivity and delayed recovery have been linked prospectively to health 
outcomes (20).   
That associations between reactivity and vaccine response emerged in the same 
direction for both thymus-dependent (influenza) and thymus-independent (meningococcal A) 
antigens testifies to the broad generality of this relationship.  It also may indicate something 
of the mechanism underlying the association.  Antibody responses to thymus-independent 
vaccines do not require or receive T-lymphocyte help.  As both types of response were 
related to cardiovascular reactivity in the present study, this would imply that greater 
cardiovascular reactivity is associated with the healthy functioning of B cells in some way 
rather than just T cells.   
These findings were contrary to initial expectations based on the results from the two 
small-scale studies of cardiovascular reactivity and response to vaccination.  It has been 
reported that individuals with lower T-cell responses, measured by the influenza-virus-
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specific IL-2 production in vitro three months following influenza vaccination, exhibited 
larger pre-ejection period reactions to mental arithmetic and speech tasks (11, 12).  However, 
the analysis was based on eight female participants with a mean age of 67 years, clearly a 
very different sample in terms of size and characteristics to the present one.  Further, a very 
different outcome measure, the cellular secondary response to antigenic re-challenge in vitro, 
was used; the present study monitored the humoral antibody response in vivo.  Accordingly, 
the relevance of this study to the present one is unclear.   
In a study of 30 medical students who had undergone the hepatitis B vaccinations on 
average almost a year earlier, participants with lower antibody titres exhibited larger cardiac 
reactions to mental arithmetic (13).  However, those with higher antibody titres also showed 
greater total peripheral resistance, a marker of alpha-adrenergic activation, reactions to the 
stress task.  This latter result is consistent with the direction of the current findings for 
diastolic blood pressure change.  Other variations in results between our present and 
previous study may be due to the examination of different vaccines with different 
administration protocols.  The hepatitis B programme comprises two initial injections one 
month apart, plus a booster injection at six months.  Since blood sampling was undertaken 
subsequent to this booster injection, the antibody response measured in this study would 
have been a purely secondary response involving exclusively memory B cells.   In the 
present study, the vaccines utilised would have elicited a mixture of primary and secondary 
antibody response, dependent on prior exposure, via both memory and naïve lymphocytes.  
Thus, it is possible that the nature of the association between cardiovascular activity and 
antibody status following vaccination varies with the type of antibody response mounted.  
Admittedly, this is speculative and only further study using novel antigen administration will 
help resolve whether an individual’s general sympathetic nervous system responsiveness has 
differing consequences for primary and secondary antibody responses (21).   
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The present findings are consistent with the results of experimental animal studies 
showing that the optimal immune response is greatly enhanced by exposure to acute stress 
(22).  Similarly, a recent human study from our laboratory exposed participants to mental 
arithmetic or exercise stress immediately prior to vaccination (23).  Both stress tasks induced 
significant heart rate increases, and women exposed to the acute stressors had higher peak 
antibody responses to the A/Panama influenza strain than women in a no stress control 
condition (23).  In addition, acute stress exposure prior to vaccination was also associated 
with an enhanced antibody response to meningococcal A in men (24).  Finally, we have also 
found in this sample that responders to A/Panama showed a greater cortisol response to the 
acute stress task (25). 
The present study suffered from a number of limitations.  First, it was small in terms 
of the power to detect statistically significant effects, although it was noticeably larger than 
the two previous studies of cardiovascular reactivity and the antibody response to 
vaccination.  Further, the effect sizes were substantial according the recommended criterion 
for large effects: η2 > .138 (26).  Second, the sample was healthy and relatively 
homogeneous.  Indeed, the magnitude of the antibody response to vaccination was such for 
one of the influenza viral strains that it precluded analysis.  Future studies would benefit 
from examining older populations, where reduced vaccine efficacy is observed and 
participants would be less likely to mount a four-fold antibody response (e.g. (27)), 
providing greater variation and hence more power to detect associations with variables such 
as cardiovascular reactivity.  Third, it should be conceded that with the antibody response to 
four vaccine strains, and with three cardiovascular variables, a substantial number of 
statistical comparisons were undertaken.  This clearly increases the likelihood of Type I 
errors.  However, there were five statistically significant interaction effects, four telling a 
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broadly similar, from 12 interaction effects tested: an outcome that far exceeded chance.  
Finally, it is impossible to determine causation from a cross-sectional observational study.   
   In conclusion, participants who showed a four-fold increase in antibody titre to both 
influenza and meningococcal A vaccine challenges demonstrated greater blood pressure 
reactivity towards the end of their exposure to acute mental stress.  That this occurred for 
both thymus-dependent and thymus-independent vaccine strains indicates the consistency of 
the association.  There was also some evidence of delayed diastolic blood pressure recovery 
in vaccine responders.  As such, the present results challenge the contention that heightened 
cardiovascular reactivity and delayed recovery are necessarily detrimental to health since 
they appear to be related to an enhanced immune response to antigen challenge.   
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 Table 1. Number (%) of participants with and without a four-fold response to each 
vaccine strain 
 
 
Strain 
 
Responders 
 
Non-Responders 
   
A/New Caledonia/20/99 54 (98%) 1 
A/Panama/2007/99 36 (66%) 19 
B/Shangdong/7/97 49 (89%) 6 
Meningitis A 44 (80%) 11 
Meningitis C 28 (58%) 20 
   
 
 
 
 
 20
Figure 1:  Cardiovascular change by influenza A/Panama and B/Shangdong antibody status 
post-vaccination.   
 
Figure 2:  Cardiovascular change by meningococcal A and C antibody status Post-
Vaccination. 
  
 21
 
6-min baseline   
2-min anticipation      
8-min task (minutes 9-16)      
30-min recovery (minutes 17-46) 
baseline8 10 12 14 16 18 20 23 29 33 39 43
D
BP
 c
ha
ng
e 
fro
m
 b
as
el
in
e 
(m
m
H
g)
-5
0
5
10
15
20
A/Panama 4-fold responders
A/Panama non-responders
baseline8 10 12 14 16 18 20 23 29 33 39 43
SB
P 
ch
an
ge
 fr
om
 b
as
el
in
e 
(m
m
H
g)
-5
0
5
10
15
20
A/Panama 4-fold responders
A/Panama non-responders
Minutes
baseline8 10 12 14 16 18 20 23 29 33 39 43
D
B
P 
ch
an
ge
 fr
om
 b
as
el
in
e 
(m
m
H
g)
-5
0
5
10
15
20
B/Shangdong 4-fold responders
B/Shangdong non-responders
Post-print, not final published version. Cite this article as: Phillips, A.C., Carroll., D., Burns, 
V.E., & Drayson, M. (2009). Cardiovascular activity and the antibody response to 
vaccination. Journal of Psychosomatic Research, 67, 37-43. 
http://dx.doi.org/10.1016/j.jpsychores.2008.12.002 
 
 
6-min baseline   
2-min anticipation      
8-min task (minutes 9-16)       
baseline 8 10 12 14 16 18 20 23 29 33 39 43
D
B
P
 c
ha
ng
e 
fro
m
 b
as
el
in
e 
(m
m
H
g)
-5
0
5
10
15
20
Meningitis A 4-fold responders
Meningitis A non-responders
Minutes
baseline 8 10 12 14 16 18 20 23 29 33 39 43
H
R
 c
ha
ng
e 
fro
m
 b
as
el
in
e 
(b
pm
)
-5
0
5
10
15
20
Meningitis C 4-fold responders
Meningitis C non-responders
 1
30-min recovery (minutes 17-46) 
 
